Vimarsana
Biggest News Aggregation in the World

Page 12 - Toddler Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Toddler Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Toddler Development Today - Breaking & Trending Today

Efficacy of maternal vitamin B12 supplementation for improving infant outcomes in settings with high deficiency - Vimarsana News

Efficacy of maternal vitamin B12 supplementation for improving infant outcomes in settings with high deficiency

Maternal vitamin B12 supplementation to improve early neurodevelopment in infants has been proposed for some time now because vitamin B12 is a neurotropic vitamin, and infant neurodevelopment and growth are important dimensions for attained human capital and a healthy and successful adult life. In The Lancet, Ram K Chandyo and colleagues1 report a community-based, double-blind, randomised controlled trial in a Nepalese region, which is endemic for biochemical vitamin B12 deficiency. Chandyo and colleagues1 evaluated the effect of daily maternal vitamin B12 supplementation (50 μg per day) from...

Barnard psychologist Tovah Klein: Top key for raising successful kids - Vimarsana News

Barnard psychologist Tovah Klein: Top key for raising successful kids

The quality of the time you spend with your kids matters more for their development and future success than quantity, says Barnard psychologist Dr. Tovah Klein.

Source: cnbc.com
F. Hoffmann-La Roche Ltd: New four year data for Roche's Evrysdi reinforce long-term efficacy and safety profile in some of the most severely affected people with types 2 and 3 spinal muscular atrophy (SMA) - Vimarsana News

F. Hoffmann-La Roche Ltd: New four year data for Roche's Evrysdi reinforce long-term efficacy and safety profile in some of the most severely affected people with types 2 and 3 spinal muscular atrophy (SMA)

Data from pivotal SUNFISH study showed increases in motor function observed during the first year were maintained through the fourth year, while the overall rate of adverse events continued to decrease

Additional Positive Interim Data from Phase I/II/III CAMPSIITE™ Trial of REGENXBIO's RGX-121 for the Treatment of MPS II (Hunter Syndrome) Presented at 19th Annual WORLDSymposiumTM - Vimarsana News

Additional Positive Interim Data from Phase I/II/III CAMPSIITE™ Trial of REGENXBIO's RGX-121 for the Treatment of MPS II (Hunter Syndrome) Presented at 19th Annual WORLDSymposiumTM

RGX-121, a potential one-time gene therapy for the treatment of MPS II, continues to be well-tolerated with no drug-related SAEs across three dose levels...

Are your kids mean — or are they just acting their age? - Vimarsana News

Are your kids mean — or are they just acting their age?

A little brother falls down and starts crying, and his big sister laughs maniacally. A kindergartner roughly shoves a friend who reaches for a coveted toy. An 11-year-old has a thoughtful conversation...

Source: theday.com